Meeting
2019 ASCO Annual Meeting
Whole transcriptome sequencing in metastatic cancer: A review of expression outliers in 113 metastatic breast cancer patients.
Authors
Nathalie LeVasseur
BC Cancer Agency, Vancouver, BC, Canada
Nathalie LeVasseur , Veronika Csizmok , Melika Bonakdar , Yaoqing Shen , Lindsay Zibrik , Eric Yang Zhao , Sophie Sun , Karen A. Gelmon , Janessa J. Laskin , Marco A. Marra , Stephen K. L. Chia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics and Tumor Biology (Nonimmuno)
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Citation
J Clin Oncol 37, 2019 (suppl; abstr 3080)
DOI
10.1200/JCO.2019.37.15_suppl.3080
Abstract #
3080
Poster Bd #
72
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Defining resistance mechanisms to CDK4/6 inhibition in hormone receptor-positive HER2-negative metastatic breast cancer (MBC) through a machine learning approach applied to circulating tumor DNA (ctDNA).
First Author: Lorenzo Gerratana
First Author: Neal A. Fischbach
Poster
2022 ASCO Annual Meeting
Molecular alterations associated with rapid progression following CDK4/6 inhibitors (CDKi) in metastatic hormone receptor–positive breast cancer (mHRBC).
First Author: Malinda T West
Poster
2022 ASCO Annual Meeting
Clinicopathologic characterization of ERK2 E322K mutation in solid tumors: Implications for treatment and drug development.
First Author: Dazhi Liu